QIAcuity EG PCR Kit

供QIAcuity 数字 PCR 仪器使用

S_9797_dPCR_QIAcuity_EG_PCR_Kit

✓ 全天候自动处理在线订单

✓ 博学专业的产品和技术支持

✓ 快速可靠的(再)订购

QIAcuity EG PCR Kit (1 ml)

目录编号 / ID.   250111

1 ml 3x 浓缩 QIAcuity EvaGreen 预混液,2 x 1.9 ml 水
JP¥19,000
登录 要查看您的账户定价。
体积
1 ml
5 ml
25 ml
QIAcuity EG PCR Kit 旨在用于分子生物学应用。该产品不能用于疾病诊断、预防和治疗。

✓ 全天候自动处理在线订单

✓ 博学专业的产品和技术支持

✓ 快速可靠的(再)订购

特点

  • 适用于使用 EvaGreen 的染料基数字 PCR 反应
  • 3x 浓缩预混液,可加载更大体积样本
  • 针对在 QIAcuity 纳米微孔板中的微流体使用优化
  • 符合 REACH 法规

产品详情

QIAcuity EG PCR Kit 包含一份针对在 QIAcuity 纳米板中的微流体使用优化的 3x 浓缩即用型预混液。该试剂盒提高了染料法数字 PCR 的特异性和效率,可提供准确的定量分析。EvaGreen 是一种嵌合染料,结合到双链 DNA 上,可提高在QIAcuity dPCR 系统上 gDNA 或 cDNA 定量的准确性。

该试剂盒应与 QIAcuity Digital PCR SystemQIAcuity 纳米微孔板配合使用。

您想要进一步了解该产品并让我们的 dPCR 专家联系您吗?请在这里登记,我们将很快与您联系。

绩效


基于 EvaGreen 染料法的 QIAcuity 预混液中使用了最新版的 QIAGEN 高品质 DNA 聚合酶,展现出卓越的性能。QIAGEN 的专有技术与经过优化验证的专门针对纳米微孔板微流体优化的缓冲液技术的独特结合以及新的 QuantiNova DNA 聚合酶的采用可保证在灵敏度、可重复性及效率等方面高度一致的结果。

使用 EvaGreen 染料法检测
QIAcuity EG PCR Kit 中的独特预混液使您可获得准确的双链 DNA 靶标扩增和定量。该试剂盒中含有 dPCR 分析及纳米板中可分析反应器数目的计数所需的经过优化的参比染料。此外,与相同浓度的 SYBR Green 相比,EvaGreen 可提供更强的荧光信号,在 dPCR 中实现最大化的扩增效率、特异性和灵敏度。

长达 100 个小时的反应稳定性
QIAcuity PCR 混合物可在 30°℃ 下存放长达 100 个小时,而不会影响后续反应的性能。优异的稳定性——即便在室温下不使用冷却剂的情况下存放很长时间后仍是稳定的,使得 QIAcuity EG PCR Kit 成为高通量体系构建及孔板堆叠处理时的理想选择。

原理

QIAcuity EG PCR Kit 采用了新型抗体介导的热启动,因而具有cDNA 或 gDNA 分析具有高的特异性。在低温下,QuantiNova DNA 聚合酶在 QuantiNova 抗体和 QuantiNova Guard(一款具有复合物稳定化作用的新型添加剂)的作用下保持在失活状态。这可提高热启动的严格性并防止非特异性退火引物的延伸及引物二聚体的形成。在温度升高到 95°℃的两分钟内,QuantiNova 抗体和 QuantiNova Guard 将发生变性,QuantiNova DNA 聚合酶将被激活,从而启动 PCR 扩增。

有关纳米微孔板中 dPCR 的反应的原理说明,请参见这里

程序

与qPCR 类似,dPCR样本制备包括将预混液、探针和引物转移到一个 96 孔或 24 孔纳米微孔板中,随后添加样本。该系统将微分化、热循环和成像集成到单一全自动仪器上,用户可在 2 小时内实现样本进,数据出。您可在软件套组上执行分析,该软件可针对您的靶序列及质量控制(例如阳性样本或无模板对照)给出以每微升拷贝数表示的浓度。该分析还可在同一局域网上的远程计算机上执行。

应用

QIAcuity EG PCR Kit 与 QIAcuity Digital PCR System 和 QIAcuity 纳米板的结合使用可让您在各种应用中进行 cDNA 靶标和 gDNA 定量分析,这些应用包括:

  • 罕见突变检测
  • 拷贝数变异分析
  • 基因表达分析
  • 病原体检测
  • 基因分型
  • miRNA 研究

辅助数据和图表

资源

操作软件 (8)
For Version 2
Version 4.0

The Volume Precision Factor (VPF) offers a unique feature to secure precision of concentration results obtained from a QIAcuity dPCR run. 
In general, Nanoplates provide partitions of fixed sizes that enable a very precise way of sample concentration calculation. Potential variation of partition sizes in Nanoplate batches, caused by different microstructure molding forms, can be addressed by applying the batch specific VPF. Furthermore, the VPF includes well-specific volume information and therefore further increases precision of concentration calculation in each well of the Nanoplates.

After downloading and updating the VPF file within the QIAcuity Software Suite, the VPF is applied automatically to the analysis of a corresponding Nanoplate batch. The VPF file includes information from all available microstructure molding forms and connected Nanoplate batches. It will be stored on the PC where the QIAcuity Software Suite is installed. 

Required QIAcuity Software Suite version: Version 1.2 or higher.

Version 2.1

QIAcuity Software Suite
SOFTWARE (389MB)

Version 1.2

The QIAcuity Software Suite 1.2 is designed to be installed on a Windows PC that is connected to one or more QIAcuity instruments. The QIAcuity Software Suite enables the user to set up plates, analyze results, and monitor the status of runs in real time. For this configuration, the QIAcuity instrument needs to be connected to a network through Ethernet. Alternatively, a direct cable connection between the QIAcuity and the notebook where the QIAcuity Software Suite is running needs to be established. When connected to a network, up to 10 users may access the QIAcuity Software Suite via a browser installed on the client PC (Windows or Mac).

The following browsers are supported in the QIAcuity Software Suite:

-Mozilla Firefox (version 64.0.2 or higher)
-Microsoft Edge (version 44.17763.1.0 or higher)
-Google Chrome (version 71.0.3578.98 or higher)

The new QIAcuity Software Suite 1.2 offers a functionality that enables users of the QIAcuity Software 1.1.3 to upgrade to the new version while keeping the library of previously stored plate runs.

Note: If you have exported plates from QIAcuity Software Suite 1.1.3 that you would like to import and use in QIAcuity Software Suite 1.2, you will need to import the plates before upgrading from version 1.1.3 to version 1.2. You may then export the plates again. Future software version starting from QIAcuity Software Suite 2.0 will facilitate import of plates from previous QIAcuity Software Suite versions.

The new improvements are as follows:

-Support for the Nanoplate 8.5k 24-well
-Hyperwell functionality to combine several wells to one combined well for analysis
-Automated plate archiving functionality
-Functionality to show the number of single/double positives in 2D scatterplots
-VPF (Volume Precision Factor) to further improve concentration calculation (see related resources)
-Additional improvements for stabilization and troubleshooting

For Version 1.2
用户使用手册 (2)
在线讲座 (5)
Limitations of conventional PCR and qPCR when dealing with difficult, low-volume samples and complex mixtures with high background of competitive molecules and inhibitors have posed frequent challenges for researchers and clinicians in their routine work. With the new generation of PCR technologies, digital PCR has opened doors for diverse applications, and researchers are learning to ask questions only digital PCR can answer. Join QIAGEN's webinar on how digital PCR can help take your research applications through and beyond those challenges.
This presentation will introduce dPCR, discuss its advantages, and outline how the approach might be used to improve measurement in areas like clinical diagnosis, alone or in conjunction with other methods.
In this expert webinar, Dr. Kubista will share with you the experience he and his team have gathered at the TATAA Biocenter, developing applications and providing services using digital PCR for nearly 12 years. They have experienced all the problems common to dPCR analytical workflows and developed robust standard operating procedures to minimize the risk of error and maximize robustness and repeatability, and developed various controls to test the performance and validate the methods. He will also discuss dPCR assay design and validation and then focus on strategies for copy number determination and rare mutation detection.
The QIAGEN digital PCR technology and its expanded capability will not only transform the portfolio of conventional qPCR applications but also provide a more rapid, accurate, and sensitive method for finding answers to difficult biological questions. 
As the digital PCR technology evolves and becomes more accessible and affordable, the transition from qPCR and adoption of dPCR will hopefully no longer remain a challenge. Experts share insights in an upcoming webinar about the fully integrated, rapid, and highly flexible digital PCR portfolio from QIAGEN. 
试剂盒操作手册 (1)
For highly sensitive detection of miRNA using EvaGreen
Certificates of Analysis (1)